A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillation.

[1]  P. Wolf,et al.  Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study , 2011, Neurology.

[2]  K. Stroumpoulis,et al.  A formula for the stratified selection of patients with paroxysmal atrial fibrillation in the emergency setting: a retrospective pilot study. , 2011, The Journal of emergency medicine.

[3]  T. Alonzo.  Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating By Ewout W. Steyerberg , 2009 .

[4]  C.J.H. Mann,et al.  Clinical Prediction Models: A Practical Approach to Development, Validation and Updating , 2009 .

[5]  D. Levy,et al.  Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.

[6]  D. Roden,et al.  Abstract 4099: Genetic and Clinical Predictors of Response to Rate Control Therapy in Patients with Atrial Fibrillation , 2008 .

[7]  L. Stead,et al.  A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillation. , 2008, Annals of emergency medicine.

[8]  G. Novo,et al.  Risk factors, atrial fibrillation and thromboembolic events. , 2008, International angiology : a journal of the International Union of Angiology.

[9]  H. Hod,et al.  Treatment of Stable Atrial Fibrillation in the Emergency Department: A Population-Based Comparison of Electrical Direct-Current versus Pharmacological Cardioversion or Conservative Management , 2008, Cardiology.

[10]  James B Seward,et al.  Changing trends of hospital utilization in patients after their first episode of atrial fibrillation. , 2008, The American journal of cardiology.

[11]  Jane A. Linderbaum,et al.  ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults with Nonvalvular Atrial Fibrillation or Atrial Flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Wr , 2008, Journal of the American College of Cardiology.

[12]  Jane A. Linderbaum,et al.  ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Wr , 2008, Circulation.

[13]  C. Camargo,et al.  Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004. , 2008, Annals of emergency medicine.

[14]  I. Stiell,et al.  Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter. , 2007, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[15]  T. Iwamoto,et al.  Plasma brain natriuretic peptide levels indicating thromboembolism in very elderly patients with non-valvular atrial fibrillation. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[16]  M. Main,et al.  Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation. , 2007, The American journal of cardiology.

[17]  J. Hollander,et al.  The risk for acute coronary syndrome associated with atrial fibrillation among ED patients with chest pain syndromes. , 2007, The American journal of emergency medicine.

[18]  V. Pasceri,et al.  Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion. , 2007, The American journal of cardiology.

[19]  Panagiotis Korantzopoulos,et al.  Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. , 2007, Journal of the American College of Cardiology.

[20]  G. Lip,et al.  High-Sensitivity C-Reactive Protein and Soluble CD40 Ligand as Indices of Inflammation and Platelet Activation in 880 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors, Stroke Risk Stratification Schema, and Prognosis , 2007, Stroke.

[21]  Samuel Wann,et al.  [Guidelines for the management of patients with atrial fibrillation. Executive summary]. , 2006, Revista espanola de cardiologia.

[22]  A Rogier T Donders,et al.  Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. , 2006, Journal of clinical epidemiology.

[23]  T. Stijnen,et al.  Review: a gentle introduction to imputation of missing values. , 2006, Journal of clinical epidemiology.

[24]  Matthew Reynolds,et al.  Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[25]  Silvia G Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit , 2006, Journal of the American College of Cardiology.

[26]  G. Lip,et al.  Anticoagulation for stroke prevention in atrial fibrillation: is gender important? , 2006, European heart journal.

[27]  E. Watanabe,et al.  High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. , 2006, International journal of cardiology.

[28]  Alfonso Martín,et al.  Analysis of current management of atrial fibrillation in the acute setting: GEFAUR-1 study. , 2005, Annals of emergency medicine.

[29]  M. Brezocnik,et al.  Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[30]  A Rogier T Donders,et al.  Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism: a clinical example. , 2004, Journal of clinical epidemiology.

[31]  L. Drouet,et al.  D-dimer can predict survival in patients with chronic atrial fibrillation , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[32]  A. Avşar,et al.  P-wave dispersion for predicting maintenance of sinus rhythm after cardioversion of atrial fibrillation. , 2004, The American journal of cardiology.

[33]  G. Jensen,et al.  Rising Rates of Hospital Admissions for Atrial Fibrillation , 2003, Epidemiology.

[34]  K. Kosmelj,et al.  High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy , 2003, Thrombosis and Haemostasis.

[35]  M. Josephson,et al.  Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. , 2003, The American journal of cardiology.

[36]  Ralph B D'Agostino,et al.  A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. , 2003, JAMA.

[37]  U. Tebbe,et al.  Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. , 2003, Journal of the American College of Cardiology.

[38]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[39]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.

[40]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2002 .

[41]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[42]  A. Pancioli,et al.  Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients , 2002, Stroke.

[43]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[44]  M. Ross,et al.  An emergency department observation unit protocol for acute-onset atrial fibrillation is feasible. , 2002, Annals of emergency medicine.

[45]  Takashi Sugamori,et al.  High Plasma Brain Natriuretic Polypeptide Level as a Marker of Risk for Thromboembolism in Patients With Nonvalvular Atrial Fibrillation , 2002, Stroke.

[46]  M. Rich,et al.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.

[47]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[48]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[49]  M. Josephson,et al.  Incidence and predictors of myocardial infarction among patients with atrial fibrillation. , 2000, Journal of the American College of Cardiology.

[50]  T. Marrie,et al.  A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. , 2000, JAMA.

[51]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[52]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[53]  J. Steiner,et al.  Chart reviews in emergency medicine research: Where are the methods? , 1996, Annals of emergency medicine.

[54]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[55]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[56]  A Laupacis,et al.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.

[57]  M. Sayre,et al.  A rapid diagnostic and treatment center for patients with chest pain in the emergency department. , 1995, Annals of emergency medicine.

[58]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[59]  S. Glantz,et al.  Primer of Applied Regression & Analysis of Variance , 1990 .

[60]  S. Glantz.  Primer of applied regression and analysis of variance / Stanton A. Glantz, Bryan K. Slinker , 1990 .

[61]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.